Skip to main content
  • ASM
    • Antimicrobial Agents and Chemotherapy
    • Applied and Environmental Microbiology
    • Clinical Microbiology Reviews
    • Clinical and Vaccine Immunology
    • EcoSal Plus
    • Eukaryotic Cell
    • Infection and Immunity
    • Journal of Bacteriology
    • Journal of Clinical Microbiology
    • Journal of Microbiology & Biology Education
    • Journal of Virology
    • mBio
    • Microbiology and Molecular Biology Reviews
    • Microbiology Resource Announcements
    • Microbiology Spectrum
    • Molecular and Cellular Biology
    • mSphere
    • mSystems
  • Log in
  • My alerts
  • My Cart

Main menu

  • Home
  • Articles
    • Current Issue
    • Accepted Manuscripts
    • COVID-19 Special Collection
    • Archive
    • Minireviews
  • For Authors
    • Submit a Manuscript
    • Scope
    • Editorial Policy
    • Submission, Review, & Publication Processes
    • Organization and Format
    • Errata, Author Corrections, Retractions
    • Illustrations and Tables
    • Nomenclature
    • Abbreviations and Conventions
    • Publication Fees
    • Ethics Resources and Policies
  • About the Journal
    • About JCM
    • Editor in Chief
    • Editorial Board
    • For Reviewers
    • For the Media
    • For Librarians
    • For Advertisers
    • Alerts
    • RSS
    • FAQ
  • Subscribe
    • Members
    • Institutions
  • ASM
    • Antimicrobial Agents and Chemotherapy
    • Applied and Environmental Microbiology
    • Clinical Microbiology Reviews
    • Clinical and Vaccine Immunology
    • EcoSal Plus
    • Eukaryotic Cell
    • Infection and Immunity
    • Journal of Bacteriology
    • Journal of Clinical Microbiology
    • Journal of Microbiology & Biology Education
    • Journal of Virology
    • mBio
    • Microbiology and Molecular Biology Reviews
    • Microbiology Resource Announcements
    • Microbiology Spectrum
    • Molecular and Cellular Biology
    • mSphere
    • mSystems

User menu

  • Log in
  • My alerts
  • My Cart

Search

  • Advanced search
Journal of Clinical Microbiology
publisher-logosite-logo

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Accepted Manuscripts
    • COVID-19 Special Collection
    • Archive
    • Minireviews
  • For Authors
    • Submit a Manuscript
    • Scope
    • Editorial Policy
    • Submission, Review, & Publication Processes
    • Organization and Format
    • Errata, Author Corrections, Retractions
    • Illustrations and Tables
    • Nomenclature
    • Abbreviations and Conventions
    • Publication Fees
    • Ethics Resources and Policies
  • About the Journal
    • About JCM
    • Editor in Chief
    • Editorial Board
    • For Reviewers
    • For the Media
    • For Librarians
    • For Advertisers
    • Alerts
    • RSS
    • FAQ
  • Subscribe
    • Members
    • Institutions
Letter to the Editor

Evaluation of a New Commercial Microarray Platform for the Simultaneous Detection of β-Lactamase and mcr-1 and mcr-2 Genes in Enterobacteriaceae

Odette J. Bernasconi, Luigi Principe, Regula Tinguely, Aneta Karczmarek, Vincent Perreten, Francesco Luzzaro, Andrea Endimiani
Erik Munson, Editor
Odette J. Bernasconi
aInstitute for Infectious Diseases, University of Bern, Bern, Switzerland
bGraduate School of Cellular and Biomedical Sciences, University of Bern, Bern, Switzerland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Luigi Principe
cClinical Microbiology and Virology Unit, A. Manzoni Hospital, Lecco, Italy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Regula Tinguely
aInstitute for Infectious Diseases, University of Bern, Bern, Switzerland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Aneta Karczmarek
dCheck-Points, B.V., Wageningen, The Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Vincent Perreten
eInstitute of Veterinary Bacteriology, University of Bern, Bern, Switzerland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Vincent Perreten
Francesco Luzzaro
cClinical Microbiology and Virology Unit, A. Manzoni Hospital, Lecco, Italy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Andrea Endimiani
aInstitute for Infectious Diseases, University of Bern, Bern, Switzerland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Andrea Endimiani
Erik Munson
Marquette University
Roles: Editor
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
DOI: 10.1128/JCM.01056-17
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

LETTER

The worldwide prevalence of infections due to Gram-negative bacteria coresistant to extended-spectrum cephalosporins and carbapenems is worrisome. For these organisms, polymyxins are considered the last-resort antibacterials. Thus, the recent emergence of the plasmid-mediated colistin resistance genes mcr-1, mcr-2, and mcr-3 has become an alarming public health issue (1, 2) that urges rapid and reliable detection methods (3–6).

In this work, we evaluated the performance of the new commercial CT103XL microarray system (Check-Points). In ∼6.5 h (starting from culture strains) and for a cost ranging from 50 to 85€, this platform allows the detection of mcr-1 (including the variants from mcr-1.2 to mcr-1.7) and mcr-2 determinants. Along with them, clinically important class A, B, C, and D β-lactamase (bla) genes are simultaneously detected, as in the former version (CT103XL) that has demonstrated an overall accuracy of >94% (7).

We tested 106 Enterobacteriaceae isolates of human, animal, and food origin consisting of 80 strains of Escherichia coli, 14 of Klebsiella pneumoniae, and 12 of other species (Table 1). Most isolates were phenotypically (e.g., MICs for colistin) and molecularly (i.e., PCR/sequencing of mcr-1 and mcr-2 and bla genes or whole-genome sequencing) characterized in previous studies (4, 8–11) (see also Table S1 in the supplemental material). Sixty-one strains (57.5%) were resistant to colistin (12), of which 30 were positive for mcr-1 (including one positive for mcr-1.2) and two were positive for mcr-2. This group of 32 isolates (30.2%) included 7 blaESBL and one blaCMY-2 carrier, as well as 24 without bla or possessing only blaTEM-1-like. The other 74 mcr-1- and mcr-2-negative strains included 32 carbapenemase- and 24 extended-spectrum β-lactamase (ESBL)- and/or pAmpC-producing strains (Table S1).

View this table:
  • View inline
  • View popup
TABLE 1

Origin, resistance genes, and accuracy in detecting mcr-1 and mcr-2 of the new CT103XL microarray for the 106 tested strains

Total bacterial DNA was rapidly extracted from fresh cultured bacteria using Chelex-100 resin (Sigma-Aldrich). In the case of an unclear result, a new extraction was performed using the High Pure PCR template preparation kit (Roche). Then, microarray analyses were performed according to the manufacturer's instructions. The new CT103XL uses a multiplex ligation detection reaction. In brief, each probe consists of two arms containing target gene-specific sequence, a universal primer binding site, and a ZIP code for the hybridization (Fig. S1A). Ligated and amplified probes are hybridized to the microarray, visualized using biotin label incorporated into the primer, and automatically interpreted by software (13).

The mcr-1 and mcr-2 genes were correctly detected by the new array system in all 32 isolates (Table 1). In particular, the 30 mcr-1 carriers displayed positive reactions with all three new hybridization spots (Fig. S1B), corresponding to mcr-1 detection. On the other hand, both mcr-2-harboring strains displayed positive results with two of the three spots, revealing mcr-2 (Fig. S1C). Two microarray analyses had to be repeated due to inadequate template concentration. The second run, performed with new DNA extracts, yielded correct results (Table S1). Moreover, all 74 strains lacking mcr-1 and mcr-2 resulted negative after microarray analyses. Therefore, the new CT103XL platform showed 100% accuracy in identifying mcr-1 and mcr-2. We also noted that all bla genes were correctly identified (Table S1), thereby confirming previous validations (7, 14, 15).

This work demonstrated the ability and accuracy of the new CT103XL array to simultaneously identify mcr-1 and mcr-2 and clinically important bla genes. This strengthened platform represents therefore an essential tool for clinical laboratories, especially for the rapid characterization of large collections of multidrug-resistant Gram-negative bacteria, providing essential epidemiological data. The test is unable to detect the recently described mcr-3 (only 45% and 47% identity to mcr-1 and mcr-2, respectively) (2), but the flexibility of the microarray allows easy and rapid updating of the platform to include novel and emerging antimicrobial resistance traits.

ACKNOWLEDGMENTS

This work was supported by the Swiss National Science Foundation (SNF grant no. 153377 to A.E.). Odette J. Bernasconi is a Ph.D. student (2015 to 2018) supported by the Hans Sigrist Foundation (Bern, Switzerland).

A.K. is an employee of Check-Points. The new CT103XL microarrays used in the present study were provided for free by Check-Points to A.E.

We thank Surbhi Malhotra-Kumar (University of Antwerp, Wilrijk, Belgium) for donating the mcr-2-positive E. coli strain.

FOOTNOTES

    • Accepted manuscript posted online 2 August 2017.
  • Supplemental material for this article may be found at https://doi.org/10.1128/JCM.01056-17 .

  • Copyright © 2017 American Society for Microbiology.

All Rights Reserved .

REFERENCES

  1. 1.↵
    1. Poirel L,
    2. Jayol A,
    3. Nordmann P
    . 2017. Polymyxins: antibacterial activity, susceptibility testing, and resistance mechanisms encoded by plasmids or chromosomes. Clin Microbiol Rev30:557–596. doi:10.1128/CMR.00064-16.
    OpenUrlAbstract/FREE Full Text
  2. 2.↵
    1. Yin W,
    2. Li H,
    3. Shen Y,
    4. Liu Z,
    5. Wang S,
    6. Shen Z,
    7. Zhang R,
    8. Walsh TR,
    9. Shen J,
    10. Wang Y
    . 2017. Novel plasmid-mediated colistin resistance gene mcr-3 in Escherichia coli. mBio8:e00543-17. doi:10.1128/mBio.00543-17.
    OpenUrlAbstract/FREE Full Text
  3. 3.↵
    1. Jayol A,
    2. Nordmann P,
    3. Lehours P,
    4. Poirel L,
    5. Dubois V
    . 2017. Comparison of methods for detection of plasmid-mediated and chromosomally-encoded colistin resistance in Enterobacteriaceae. Clin Microbiol Infect doi:10.1016/j.cmi.2017.06.002.
    OpenUrlCrossRef
  4. 4.↵
    1. Dona V,
    2. Bernasconi OJ,
    3. Kasraian S,
    4. Tinguely R,
    5. Endimiani A
    . 2017. A SYBR Green-based real-time PCR method for improved detection of mcr-1-mediated colistin resistance in human stool samples. J Glob Antimicrob Resist9:57–60. doi:10.1016/j.jgar.2017.01.007.
    OpenUrlCrossRef
  5. 5.↵
    1. Imirzalioglu C,
    2. Falgenhauer L,
    3. Schmiedel J,
    4. Waezsada SE,
    5. Gwozdzinski K,
    6. Roschanski N,
    7. Roesler U,
    8. Kreienbrock L,
    9. Schiffmann AP,
    10. Irrgang A,
    11. Kasbohrer A,
    12. Bauerfeind R,
    13. Domann E,
    14. Chakraborty T
    . 2017. Evaluation of a loop-mediated isothermal amplification-based assay for the rapid detection of plasmid-encoded colistin resistance gene mcr-1 in Enterobacteriaceae isolates. Antimicrob Agents Chemother61:e02326-16. doi:10.1128/AAC.02326-16.
    OpenUrlFREE Full Text
  6. 6.↵
    1. Chabou S,
    2. Leangapichart T,
    3. Okdah L,
    4. Le Page S,
    5. Hadjadj L,
    6. Rolain JM
    . 2016. Real-time quantitative PCR assay with Taqman probe for rapid detection of MCR-1 plasmid-mediated colistin resistance. New Microbes New Infect13:71–74. doi:10.1016/j.nmni.2016.06.017.
    OpenUrlCrossRefPubMed
  7. 7.↵
    1. Cunningham SA,
    2. Vasoo S,
    3. Patel R
    . 2016. Evaluation of the Check-Points Check MDR CT103 and CT103 XL microarray kits by use of preparatory rapid cell lysis. J Clin Microbiol54:1368–1371. doi:10.1128/JCM.03302-15.
    OpenUrlAbstract/FREE Full Text
  8. 8.↵
    1. Pires J,
    2. Bernasconi OJ,
    3. Hauser C,
    4. Tinguely R,
    5. Atkinson A,
    6. Perreten V,
    7. Dona V,
    8. Rauch A,
    9. Furrer H,
    10. Endimiani A
    . 2017. Erratum to ‘Intestinal colonisation with extended-spectrum cephalosporin- and colistin-resistant Enterobacteriaceae in HIV-positive individuals in Switzerland: molecular features and risk factors’ [International Journal of Antimicrobial Agents 49/4 (2017) 519-521]. Int J Antimicrob Agents50:276. doi:10.1016/j.ijantimicag.2017.05.002.
    OpenUrlCrossRef
  9. 9.↵
    1. Pires J,
    2. Bernasconi OJ,
    3. Kasraian S,
    4. Hilty M,
    5. Perreten V,
    6. Endimiani A
    . 2016. Intestinal colonisation with extended-spectrum cephalosporin-resistant Escherichia coli in Swiss pets: molecular features, risk factors and transmission with owners. Int J Antimicrob Agents48:759–760. doi:10.1016/j.ijantimicag.2016.08.007.
    OpenUrlCrossRef
  10. 10.↵
    1. Pires J,
    2. Kuenzli E,
    3. Kasraian S,
    4. Tinguely R,
    5. Furrer H,
    6. Hilty M,
    7. Hatz C,
    8. Endimiani A
    . 2016. Polyclonal intestinal colonization with extended-spectrum cephalosporin-resistant Enterobacteriaceae upon traveling to India. Front Microbiol7:1069. doi:10.3389/fmicb.2016.01069.
    OpenUrlCrossRef
  11. 11.↵
    1. Bernasconi OJ,
    2. Kuenzli E,
    3. Pires J,
    4. Tinguely R,
    5. Carattoli A,
    6. Hatz C,
    7. Perreten V,
    8. Endimiani A
    . 2016. Travelers can import colistin-resistant Enterobacteriaceae, including those possessing the plasmid-mediated mcr-1 gene. Antimicrob Agents Chemother60:5080–5084. doi:10.1128/AAC.00731-16.
    OpenUrlAbstract/FREE Full Text
  12. 12.↵
    European Committee on Antimicrobial Susceptibility Testing (EUCAST). 2017. Breakpoint tables for interpretations of MICs and zone diameters, version 7.0. http://www.eucast.org.
  13. 13.↵
    1. Endimiani A,
    2. Hujer AM,
    3. Hujer KM,
    4. Gatta JA,
    5. Schriver AC,
    6. Jacobs MR,
    7. Rice LB,
    8. Bonomo RA
    . 2010. Evaluation of a commercial microarray system for detection of SHV-, TEM-, CTX-M-, and KPC-type β-lactamase genes in Gram-negative isolates. J Clin Microbiol48:2618–2622. doi:10.1128/JCM.00568-10.
    OpenUrlAbstract/FREE Full Text
  14. 14.↵
    1. Cuzon G,
    2. Naas T,
    3. Bogaerts P,
    4. Glupczynski Y,
    5. Nordmann P
    . 2012. Evaluation of a DNA microarray for the rapid detection of extended-spectrum beta-lactamases (TEM, SHV and CTX-M), plasmid-mediated cephalosporinases (CMY-2-like, DHA, FOX, ACC-1, ACT/MIR and CMY-1-like/MOX) and carbapenemases (KPC, OXA-48, VIM, IMP and NDM). J Antimicrob Chemother67:1865–1869. doi:10.1093/jac/dks156.
    OpenUrlCrossRefPubMedWeb of Science
  15. 15.↵
    1. Naas T,
    2. Cuzon G,
    3. Truong H,
    4. Bernabeu S,
    5. Nordmann P
    . 2010. Evaluation of a DNA microarray, the Check-Points ESBL/KPC array, for rapid detection of TEM, SHV, and CTX-M extended-spectrum beta-lactamases and KPC carbapenemases. Antimicrob Agents Chemother54:3086–3092. doi:10.1128/AAC.01298-09.
    OpenUrlAbstract/FREE Full Text
PreviousNext
Back to top
Download PDF
Citation Tools
Evaluation of a New Commercial Microarray Platform for the Simultaneous Detection of β-Lactamase and mcr-1 and mcr-2 Genes in Enterobacteriaceae
Odette J. Bernasconi, Luigi Principe, Regula Tinguely, Aneta Karczmarek, Vincent Perreten, Francesco Luzzaro, Andrea Endimiani
Journal of Clinical Microbiology Sep 2017, 55 (10) 3138-3141; DOI: 10.1128/JCM.01056-17

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Print

Alerts
Sign In to Email Alerts with your Email Address
Email

Thank you for sharing this Journal of Clinical Microbiology article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Evaluation of a New Commercial Microarray Platform for the Simultaneous Detection of β-Lactamase and mcr-1 and mcr-2 Genes in Enterobacteriaceae
(Your Name) has forwarded a page to you from Journal of Clinical Microbiology
(Your Name) thought you would be interested in this article in Journal of Clinical Microbiology.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Evaluation of a New Commercial Microarray Platform for the Simultaneous Detection of β-Lactamase and mcr-1 and mcr-2 Genes in Enterobacteriaceae
Odette J. Bernasconi, Luigi Principe, Regula Tinguely, Aneta Karczmarek, Vincent Perreten, Francesco Luzzaro, Andrea Endimiani
Journal of Clinical Microbiology Sep 2017, 55 (10) 3138-3141; DOI: 10.1128/JCM.01056-17
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Top
  • Article
    • LETTER
    • ACKNOWLEDGMENTS
    • FOOTNOTES
    • REFERENCES
  • Figures & Data
  • Info & Metrics
  • PDF

KEYWORDS

colistin
ESBL
Enterobacteriaceae
β-lactamases
carbapenemases
detection
diagnostics
mcr-1
mcr-2
microarrays
Drug Resistance, Bacterial
Enterobacteriaceae
Genes, Bacterial
Oligonucleotide Array Sequence Analysis
Sequence Analysis, DNA
beta-lactamases

Related Articles

Cited By...

About

  • About JCM
  • Editor in Chief
  • Board of Editors
  • Editor Conflicts of Interest
  • For Reviewers
  • For the Media
  • For Librarians
  • For Advertisers
  • Alerts
  • RSS
  • FAQ
  • Permissions
  • Journal Announcements

Authors

  • ASM Author Center
  • Submit a Manuscript
  • Article Types
  • Resources for Clinical Microbiologists
  • Ethics
  • Contact Us

Follow #JClinMicro

@ASMicrobiology

       

ASM Journals

ASM journals are the most prominent publications in the field, delivering up-to-date and authoritative coverage of both basic and clinical microbiology.

About ASM | Contact Us | Press Room

 

ASM is a member of

Scientific Society Publisher Alliance

 

American Society for Microbiology
1752 N St. NW
Washington, DC 20036
Phone: (202) 737-3600

 

Copyright © 2021 American Society for Microbiology | Privacy Policy | Website feedback

Print ISSN: 0095-1137; Online ISSN: 1098-660X